Ireland – Bio-Incubator Launched
European Biotechnology No. 5 Vol. 3
May 2004 Ireland

Dublin – Ireland is going to boost its biotech sector by investing in building up biotech incubators. At the beginning of April Dr. Cormac Kilty, Chairman of the Irish BioIndustry Association (IBIA), launched the first of six new incubation facilities to be launched in Ireland. The conversion of existing facilities into the bio-incubator, located in Trinity College’s Enterprise Centre, was funded with €750,000 by Enterprise Ireland.

“With €500 million being invested in biotech research over 5 years it is vital that our third level institutions are equally prepared and resourced to catalyse commercialisation of the intellectual property produced from this considerable investment”, stated Kilty.

“The bio-incubator in Trinity’s Enterprise Centre builds our capability to nurture spin-out companies in this sector and we anticipate to further collaborative developments of this nature in our Enterprise Centre”, said Dr. Eoin O’Neill, Director of Research and Innovation Services at Trinity College Dublin.

The first tenant for the Trinity College bio-incubator is IdentiGEN Ltd., which has developed a DNA-based traceability system for meat (TraceBackTM) from research initially carried out at the Institute of Genetics at Trinity College.

  
 
Copyright 2007 Growcorp Group. All Rights Reserved.
Office: Growcorp Group Limited, 3015 Lake Drive, Citywest Campus, Citywest, Dublin 24 | Telephone: +353 1 4661000 | Fax: +353 1 4661002
Site developed by 4wardwebdesign
2008
Galway and Dublin. Wednesday, 3rd December, 2008: Growcorp Group, the Irish investment vehicle, will earn over Eur 7m following the acquisition this week of Irish theranoistic company Neutekbio by Danish biotechnology development company Merrion Pharmaceuticals has signed a multi-million euro deal with Novo Nordisk to develop oral diabetes products.

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
Merrion Pharmaceuticals the TCD based Irish American company has confirmed that it has begun a joint feasibility study on oral drug delivery with Swiss based multinational Ferring Pharmaceuticals.

2007
Merrion Pharmaceuticals Plc was admitted to the IEX today and commenced
unconditional trading.........

2006
Merrion Pharmaceuticals Ltd, Dublin, announced the successful......        

Enterprise START Programme As Enterprise Ireland are anxious to..........

Merrion Pharma raises Eur 5M ahead of 2007 float Dublin drugmaker..........

Pharma Firm Merrion Hires Funding Adviser Merrion Pharmaceuticals.........

2004
Maher appointed MD at bioscience investment specialist Growcorp.........

Biopharma Firm Plans Drug Launch.........

Investing in Ireland From World Pharmaceutical Frontiers..........